A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | X | Z

Articles are indexed by drug names, trade names and disease terms. Bold entries refer to major references.

Key Word / Drug Name
Issue #: Page #

A

abametapir2:10
ABSSSI3:10
acne2:9; 4:9; 5:12
actinic keratosis1:12; 2:9,12
adalimumab2:10,11; 6:6,8
AGLE-1021:12
alpha-adrenergic agonist4:3-4
Amgevita®2:10-11
anakinra2:9,12
ANCA-associated vasculitis6:12
androgen receptor inhibitor2:9
anifrolumab5:12
anti-neutrophil cytoplasmic
autoantibody-associated vasculitis6:12
anti-TNF2:1-5,10,11; 6:7-8
anti-acne2:9
antibacterial5:12
antibiotic3:10; 4:3-4
anti-cancer2:9
antifungal1:5-10
antineoplastic2:9; 5:12
antiparasitic4:3-4
antiviral4:14
apremilast6:7
Arazlo™5:12
atezolizumab2:9
atopic dermatitis1:1-4; 2:9; 4:9-13,14 ; 6:12
avacopan6:12
Avsola™2:11
axatilimab3:10
azelaic acid4:3-6

B

baby products5:4
basal cell carcinoma2:9,12
benzoyl peroxide5:12
berotralstat1:12; 2:10
betamethasone2:11
bimekizumab3:1-4
binimetinib3:10
biologics2:1-5,9-10; 6:4-10
biosimilar2:10; 6:6,8
BRAF kinase inhibitor2:9; 3:10
Braftovi®3:10
brincidofovir4:14
brodalumab6:6,8
Bryhali™4:14
bullous pemphigoid4:14
butorphanol3:7
Bylvay™5:12

C

C1 esterase inhibitor2:10
C5 complement inhibitor4:14; 6:12
calcipotriene2:11
cannabinoids3:7-8
cellulite2:9
cemiplimab2:12
ceramide4:10-13
certolizumab pegol2:1-5; 6:6,8
Cervarix®2:6-8
chemical depilatories5:7-11
chlormethine hydrochloride5:12
cidofovir4:14
Cimzia®2:1-5; 6:6,8
clascoterone2:9
cleansers4:9-13
cobimetinib2:9
collagenase clostridium histolyticum2:9
condyloma acuminata2:6-8
contact dermatitis4:9-13,14
coronavirus disease 20194:9
cortexolone 17α-propionate2:9
corticosteroid1:1-4; 2:11; 4:14; 6:1-3
Cosentyx®4:14; 6:7-8
cosmetics5:1-6
Cotellic®2:9
COVID-194:9-13
crisaborole1:1-4; 2:9
cutaneous T-cell lymphoma (CTCL)5:12
cutaneous warts2:6-8

D

decision-making6:4-10
depilation5:7-11
dermal fillers2:10; 5:12
dermatomyositis5:12
dermatophyte1:5-10
dicarboxylic acid4:3,7
difelikefalin6:12
Duobrii™2:11; 6:1-3
dupilumab2:9; 3:7
Dupixent®2:9; 3:7
dystrophic epidermolysis bullosa1:12

E

eczema1:1-4; 2:9; 4:9-13,14; 6:12
education6:4-10
efinaconazole1:5-10
eflornithine hydrochloride5:7,8,10,11
electrolysis5:7-11; 6:10
Enbrel®6:6,8
encapsulated cell therapy3:10
encorafenib3:10
epidermodysplasia verruciformis2:6-8
epilation5:7-11
epitheloid sarcoma2:9
erratum6:10
erythema4:1-6
etanercept6:6,8
Eucrisa®1:1-4; 2:9

F

Fabry disease3:10
fixed combination therapy6:1-3
fragrance-free5:1-6

G

Gardasil®2:6-8
gene therapy1:12
genital warts2:6-8
golimumab2:11
graft versus host disease (GVHD)3:10; 6:12
granulomatosis with polyangiitis6:12
guselkumab2:11; 6:7-8

H

Haegarda®2:10
hair dyes5:5
hair removal5:7-11; 6:10
halobetasol propionate2:11; 4:14; 6:1-3
hand eczema4:9-13
hedgehog pathway inhibitor2:9
hereditary angioedema2:10
hidradenitis suppurativa2:10,11
HPV immunization2:6-8
Hulio®2:10,11
human papillomavirus (HPV)2:6-8
Humira®6:7-8
hyaluronic acid (HA) filler2:10,12; 5:12
hypoallergenic5:1-6
hypoplasminogenemia4:14
Hyrimoz®2:10,11

I

Idacio®2:10,11
IL-122:11; 6:7-8
IL-173:1-4; 4:14; 6:6-8
IL-232:11; 6:7-8
immune globulin intravenous (IVIg)5:12
infliximab2:11; 6:6,8
ingenol mebutate1:12
insect repellent5:5
intense pulsed light (IPL)5:8-10; 6:10
interleukin (IL)-12:9,12
irritant contact dermatitis4:9-13,14
ivermectin1:12; 4:3-4
ixekizumab6:7-8

J

Jakafi®6:12
Janus kinase (JAK) inhibitor6:12
Jublia®1:5-10
Juvéderm® Voluma™ XC2:10

K

Kaposi sarcoma2:9
keratinocyte carcinomas2:6-8
Keytruda®2:9; 5:12
Kimyrsa™3:10
Kineret®2:9,12
Klisyri®2:9,12
Korsuva™6:12
Koselugo®2:10
KPL-7161:12

L

labeling laws5:1-6
laser therapy4:4; 5:7-11; 6:10
Ledaga™5:12
Libtayo®2:11
lice1:12; 2:10
Livmarli™6:12

M

maralixibat6:12
MEK inhibitor2:9,10; 6:12
Mektovi®3:10
melanoma2:9,12; 3:10
microscopic polyangiitis6:12
microtubule inhibitor2:9,12
minocycline2:11
moisturizers4:9-13
monoclonal antibody1:12; 2:1012; 3:1-4,5-8,10
mycosis fungoides5:12

N

nail disorder1:5-10
nalbuphine3:7
naloxone3:7
naltrexone3:7
nemolizumab3:5-8
neurofibromatosis2:10; 6:12
NFX-1796:12
nomacopan4:14

O

obstetrics2:1-5
Octagam®5:12
odevixibat5:12
Odomzo®2:9
onychomycosis1:5-10
opioid receptor modulation3:7
Opzelura™6:12
oritavancin3:10
Orladeyo™1:12
Otezla®6:7

P

patient education6:4-10
PD-L1 antibody2:9,12
PDE4 inhibitor1:1-4; 2:9; 6:7
pembrolizumab2:9; 5:12
personal care products5:1-6
personal protective equipment (PPE)4:9
phenotype approach (rosacea)4:1-6
phosphodiesterase-4 inhibitor1:1-4; 2:9; 6:7
photodynamic therapy5:7-11
phyma4:1-6
Picato®1:12
plasma kallikrein inhibitor1:12
plasminogen4:14
plucking5:8-9
pomalidomide2:9
Pomalyst®2:9
pregnancy2:1-5
programmed death receptor-1 (PD-1)2:9,12; 5:12
pruritus5:12; 6:12
psoriasis2:1-5,10,11; 3:1-4; 4:14; 6:1-3,4-10
psoriatic arthritis2:10,11; 4:14
prurigo nodularis1:12; 3:5-8

R

Remicade®6:6,8
Restylane® Contour™5:12
Restylane® Defyne™2:12
Restylane® Kysse™2:10
retinoid4:1-4; 5:12; 6:1-3
risankizumab6:7-8
rosacea2:11; 4:1-6
ruxolitinib6:12
Ryplazim®4:14

S

Saphnelo™5:12
secukinumab4:14; 6:7-8
selumetinib2:10
sensitive skin5:1-6
shared decision-making6:4-10
Siliq®6:6,8
Simponi® Aria™2:11
Sklice®1:12
Skyrizi®6:7-8
smallpox4:14
sonidegib2:9
squamous cell carcinoma2:6-8,9; 5:12
Stelara®2:11
sugaring5:8-9
sunscreens5:2-5
systemic lupus erythematosus5:12

T

Taltz®6:7-8
Tavneos™6:12
tazarotene2:11; 5:12; 6:1-3
tazemetostat2:9
Tecentriq®2:9
telangiectasia4:1-6
Tembexa®4:14
threading5:8-9
tirbanibulin2:9,12
TNF-alpha2:1-5,10,11; 6:6,8
topical treatment1:1-4; 2:912
Tremfya®2:11; 6:7-8
tretinoin5:12
tumor necrosis factor-alpha2:1-5,10,11; 6:6,8
Twyneo®5:12

U

ustekinumab2:11; 6:7-8

V

vaccines2:6-8,12
Vaniqa®5:7,8,10
vemurafenib2:9
verruca vulgaris2:6-8
vixarelimab1:12

W

waxing5:8-9
Winlevi®2:9
Wynzora®2:11

X

Xeglyze™2:10

Z

Zelboraf®2:9
Zilxi™2:11

Purchase Article PDF for $1.99